TEDA Biomedical Schedules 24 September 2026 EGM to Seek Share Issuance Mandate

Bulletin Express
Sep 07

Tianjin TEDA Biomedical Engineering Company Limited has convened an Extraordinary General Meeting (EGM) for 24 September 2026 at 10:00 a.m. in Beijing to request shareholder approval for a new share-issuance mandate and related amendments to its Articles of Association.

Key resolution • Special resolution: The Board seeks authorisation to issue, within three years, additional shares representing up to 50% of the Company’s existing issued share capital.  – Any issuance using non-monetary assets would still require separate shareholder approval.  – If the Board exercises this mandate and the registered capital or share count changes, no further shareholder vote will be necessary to update the Articles of Association.  – Board approval for any such issuance must be passed by at least two-thirds of all directors and must comply with the listing venue’s securities regulations.

• Ancillary authority: One director will be empowered to finalise, submit and register the amended Articles of Association with the relevant PRC authorities, and to handle all related procedural matters.

Procedural details • Shareholders may appoint one or more proxies to attend and vote; proxy documents for H-shareholders must reach Computershare Hong Kong Investor Services Limited, and for domestic shareholders the Company’s registered address, no later than 24 hours before the meeting or poll time. • The share register will close from 21 September to 24 September 2026 (both days inclusive). Transfers for H-shares must be lodged by 4:30 p.m. on 18 September 2026 to qualify for attendance and voting rights.

Board composition As of the notice date (7 September 2026), the Board comprises two executive directors (Sun Li, Yang Zeng), four non-executive directors (He Xin, Li Ximing, Wang Lei, Xia Alan Zhe) and three independent non-executive directors (Gao Chun, Tu Xiangzhen, Chen Jiang).

Venue and contact The EGM will take place at Room 503-2, Block A, Peking University Science Park, No. 127-1 Zhongguancun North Street, Haidian District, Beijing. The Company’s registered office is located at No. 12 Tai Hua Road, The 5th Avenue, TEDA, Tianjin, PRC; fax: +86 22 5981 6909.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10